Mini Gopalan, MD
Internal Medicine · Austin, TXNPI 1720060932
Payments from drug & device makers
Across 260 payments — averaging $15.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$504
- AstraZeneca$498
- GSK$389
- Boehringer Ingelheim$317
- Sanofi-aventis U.S. LLC$262
- Novo Nordisk$258
- plus $2K from 21 others
What the payments were for
- Food & beverage$3,936100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 39 | $504 |
| AstraZeneca | 32 | $498 |
| GSK | 25 | $389 |
| Boehringer Ingelheim | 19 | $317 |
| Sanofi-aventis U.S. LLC | 16 | $262 |
| Novo Nordisk | 20 | $258 |
| Amgen | 19 | $250 |
| Amarin Pharma, Inc. | 11 | $191 |
| AbbVie(2 entities) | 11 | $187 |
| Astellas Pharma US Inc | 10 | $164 |
| Pfizer | 8 | $128 |
| Novartis | 8 | $121 |
| Abbott | 5 | $102 |
| Eisai Inc. | 6 | $97 |
| Johnson & Johnson | 5 | $80 |
| Merck | 6 | $74 |
| Esperion Therapeutics, Inc. | 3 | $47 |
| Sanofi Pasteur Inc. | 3 | $43 |
| Radius Health, Inc. | 3 | $36 |
| Sanofi | 2 | $35 |
| Redhill Biopharma Inc. | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 2 | $28 |
| Bayer | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Exact Sciences | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $16 |
How this compares
$3,936 in reported general payments places this provider in the 85th percentile of 7,675 internal medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $196 |
| Omeprazole | 13 | $117 |
| Atorvastatin Calcium | 23 | $113 |
| Amlodipine Besylate | 23 | $92 |
| Prednisone | 13 | $12 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Austin
- Theresa PhamAustin$6.3M
- Lu Ann BundrantAustin$5.4M
- Antonia DavidsonAustin$4.2M
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.